Literature DB >> 26585524

Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT.

Simon L F Walsh1, Lucio Calandriello2, Nicola Sverzellati3, Athol U Wells4, David M Hansell5.   

Abstract

OBJECTIVES: To establish the level of observer variation for the current ATS/ERS/JRS/ALAT criteria for a diagnosis of usual interstitial pneumonia (UIP) on CT among a large group of thoracic radiologists of varying levels of experience.
MATERIALS AND METHODS: 112 observers (96 of whom were thoracic radiologists) categorised CTs of 150 consecutive patients with fibrotic lung disease using the ATS/ERS/JRS/ALAT CT criteria for a UIP pattern (3 categories--UIP, possibly UIP and inconsistent with UIP). The presence of honeycombing, traction bronchiectasis and emphysema was also scored using a 3-point scale (definitely present, possibly present, absent). Observer agreement for the UIP categorisation and for the 3 CT patterns in the entire observer group and in subgroups stratified by observer experience, were evaluated.
RESULTS: Interobserver agreement across the diagnosis category scores among the 112 observers was moderate, ranging from 0.48 (IQR 0.18) for general radiologists to 0.52 (IQR 0.20) for thoracic radiologists of 10-20 years' experience. A binary score for UIP versus possible or inconsistent with UIP was examined. Observer agreement for this binary score was only moderate. No significant differences in agreement levels were identified when the CTs were stratified according to multidisciplinary team (MDT) diagnosis or patient age or when observers were categorised according to experience. Observer agreement for each of honeycombing, traction bronchiectasis and emphysema were 0.59±0.12, 0.42±0.15 and 0.43±0.18, respectively.
CONCLUSIONS: Interobserver agreement for the current ATS/ERS/JRS/ALAT CT criteria for UIP is only moderate among thoracic radiologists, irrespective of their experience, and did not vary with patient age or the MDT diagnosis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Idiopathic pulmonary fibrosis; Imaging/CT MRI etc; Interstitial Fibrosis

Mesh:

Year:  2015        PMID: 26585524     DOI: 10.1136/thoraxjnl-2015-207252

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  66 in total

1.  Correlation of ultra-low dose chest CT findings with physiologic measures of asbestosis.

Authors:  David Manners; Patrick Wong; Conor Murray; Joelin Teh; Yi Jin Kwok; Nick de Klerk; Helman Alfonso; Peter Franklin; Alison Reid; A W Bill Musk; Fraser J H Brims
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

Review 2.  Interstitial lung abnormalities: risk and opportunity.

Authors:  Samuel Y Ash; George R Washko
Journal:  Lancet Respir Med       Date:  2017-02       Impact factor: 30.700

3.  Feasibility of low-dose CT with spectral shaping and third-generation iterative reconstruction in evaluating interstitial lung diseases associated with connective tissue disease: an intra-individual comparison study.

Authors:  Xiaoli Xu; Xin Sui; Lan Song; Yao Huang; Yingqian Ge; Zhengyu Jin; Wei Song
Journal:  Eur Radiol       Date:  2019-02-08       Impact factor: 5.315

4.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Authors:  Christopher J Ryerson; Tamera J Corte; Joyce S Lee; Luca Richeldi; Simon L F Walsh; Jeffrey L Myers; Jürgen Behr; Vincent Cottin; Sonye K Danoff; Kevin R Flaherty; David J Lederer; David A Lynch; Fernando J Martinez; Ganesh Raghu; William D Travis; Zarir Udwadia; Athol U Wells; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

5.  Idiopathic pulmonary fibrosis: past, present, future-a review from Talmadge King's ATS 2016 presentation.

Authors:  S Clark Berngard; Kamyar Afshar
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients.

Authors:  Margaret L Salisbury; Leslie B Tolle; Meng Xia; Susan Murray; Nabihah Tayob; Anoop M Nambiar; Shelley L Schmidt; Amir Lagstein; Jeffery L Myers; Barry H Gross; Ella A Kazerooni; Baskaran Sundaram; Aamer R Chughtai; Fernando J Martinez; Kevin R Flaherty
Journal:  Respir Med       Date:  2017-09-12       Impact factor: 3.415

7.  Prediction of survival by texture-based automated quantitative assessment of regional disease patterns on CT in idiopathic pulmonary fibrosis.

Authors:  Sang Min Lee; Joon Beom Seo; Sang Young Oh; Tae Hoon Kim; Jin Woo Song; Sang Min Lee; Namkug Kim
Journal:  Eur Radiol       Date:  2017-09-19       Impact factor: 5.315

8.  Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Authors:  Simon L F Walsh; Toby M Maher; Martin Kolb; Venerino Poletti; Richard Nusser; Luca Richeldi; Carlo Vancheri; Margaret L Wilsher; Katerina M Antoniou; Jüergen Behr; Elisabeth Bendstrup; Kevin Brown; Lucio Calandriello; Tamera J Corte; Vincent Cottin; Bruno Crestani; Kevin Flaherty; Ian Glaspole; Jan Grutters; Yoshikazu Inoue; Maria Kokosi; Yasuhiro Kondoh; Vasileios Kouranos; Michael Kreuter; Kerri Johannson; Eoin Judge; Brett Ley; George Margaritopoulos; Fernando J Martinez; Maria Molina-Molina; António Morais; Hilario Nunes; Ganesh Raghu; Christopher J Ryerson; Moises Selman; Paolo Spagnolo; Hiroyuki Taniguchi; Sara Tomassetti; Dominique Valeyre; Marlies Wijsenbeek; Wim Wuyts; David Hansell; Athol Wells
Journal:  Eur Respir J       Date:  2017-08-31       Impact factor: 16.671

9.  [Mesenchymal abdominal tumors].

Authors:  T Helmberger
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

10.  Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease.

Authors:  Yuto Yasuda; Takashi Nomizo; Hiroaki Ozasa; Tomoko Funazo; Takahiro Tsuji; Hironori Yoshida; Yuichi Sakamori; Hiroki Nagai; Tomohiro Handa; Takeshi Kubo; Young Hak Kim
Journal:  Mol Clin Oncol       Date:  2017-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.